STAT+: FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks

Written and edited by the WorldPing NewsdeskPublished Wed, 23 Sep 2026 21:47:58 UTCUpdated Wed, 23 Sep 2026 21:47:58 UTCOriginal reporting: STAT

What happened

An FDA advisory panel has endorsed Galleri, a blood test designed by the biotech firm Grail to screen for multiple types of cancer.

An FDA advisory panel has endorsed Galleri, a blood test designed by the biotech firm Grail to screen for multiple types of cancer.
Reported by STAT and published Wed, 23 Sep 2026 21:47:58 UTC.

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.

WorldPing

BBC Science

People living near a major chemical factory in Lancashire are told they could be at risk of serious health conditions.

Brief by WorldPing · Original reporting by BBC Science

WorldPing

BBC Business

The proposals would also see benefits cut for people who are able to work but have failed to hold down a job.

Brief by WorldPing · Original reporting by BBC Business